Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation.

Vanharanta M, Voutilainen S, Nurmi T, Kaikkonen J, Roberts LJ, Morrow JD, Adlercreutz H, Salonen JT
Atherosclerosis. 2002 160 (2): 465-9

PMID: 11849672 · DOI:10.1016/s0021-9150(01)00603-7

MeSH Terms (12)

4-Butyrolactone Coronary Disease Estrogens F2-Isoprostanes Homocysteine Humans Lignans Lipid Peroxidation Male Middle Aged Multivariate Analysis Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities: